> Parexel ($PRXL) has appointed two vice presidents in its clinical research business, tasking Accenture veteran Roland Andersson with overseeing its Phase II-III unit and putting former UCB exec Thomas Senderovitz in charge of the early-phase and clinical logistics segments. More
> Europe is planning to create a publicly accessible database of clinical trial results. News